Patent Yard Sign in
Canadian application, no grantCanada

Vaccines and gene therapy compositions and methods of making and using the same

CA 2362873 A1 · Owner: Agadjanyan, Michael G. · Inventors: Weiner, David B.; Kim, Jong J.; Agadjanyan, Michael G.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Methods of inducing an immune response against an immunogen in an individual are disclosed. The methods comprise administering to the individual one or , more nucleic acid molecules that comprise a nucleotide sequence that encodes an immunogen and a nucleotide sequence that encodes a Major Histocompatibility Complex antigen. The nucleotide sequences that encode the immunogen and Major Histocompatibility Complex antigen are expressed when taken up by cells of the individual and an immune response against the immunogen is induced in the individual. Methods of reducing rejection of unmatched donor cells tissue or , organ in an individual undergoing cell tissue or organ transplantation …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 3, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 3, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 3, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 3, 2000
GrantedNo grant recorded
Term endedMarch 3, 2020
Patent numberCA 2362873 A1
Classification (IPC)A61K48/00 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedMarch 3, 2000Term endedMarch 3, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.